PET Imaging of P-glycoprotein Function Using [11C]dLop
This study has been completed.
National Institute of Mental Health (NIMH)
Information provided by:
National Institutes of Health Clinical Center (CC)
First received: January 26, 2008
Last updated: January 24, 2017
Last verified: September 4, 2014
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Estimated Study Completion Date:||September 4, 2014|
|Primary Completion Date:||No date given|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Kreisl WC, Bhatia R, Morse CL, Woock AE, Zoghbi SS, Shetty HU, Pike VW, Innis RB. Increased permeability-glycoprotein inhibition at the human blood-brain barrier can be safely achieved by performing PET during peak plasma concentrations of tariquidar. J Nucl Med. 2015 Jan;56(1):82-7. doi: 10.2967/jnumed.114.146894.